RALEIGH, N.C., June 11 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, is exhibiting our significant hematology expertise and experience at the European Hematology Association's (EHA) 15th congress in Barcelona 10-13 June 2010.
At PRA's booth (#202), conference attendees can meet with our lead hematology expert, Ute Berger, M.D., to discuss the key issues and latest developments in hematology drug development. Also at booth 202, attendees can further explore our company's other comprehensive services.
PRA's vice president of Medical Affairs and EHA's former chairwoman, Dr. Berger is board certified in hematology, oncology, and internal medicine. With 18 years of clinical experience, she is also certified by the European Society of Medical Oncology (ESMO). She possesses close contact with many therapeutic experts and investigative sites in hematology and oncology, and offers a unique perspective on this research field.
A recognized leader in hematology and oncology, PRA has participated in 96 hematology trials in 18 indications in 54 countries over the last five years as well as 275 oncology trials in 24 indications in 50 countries over the same period. Our services have contributed to the approval of many leading and innovative cancer drugs, and more than 70% of our clinical staff is experienced in hematology and oncology.
For more information about EHA's conference and our exhibit, navigate to www.praintl.com and cli
|SOURCE PRA International|
Copyright©2010 PR Newswire.
All rights reserved